USP18 and sarcoma: Defects in IFN signaling can augment tumorigenesis in the 3-MCA-sarcoma model; evidence from USP18 null mice identified an amplified IFN response as compared to wild-type mice, which is thought to provide a less permissive environment for tumors [45].